These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 7796417

  • 21. p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines.
    Hirama T, Miller CW, Wilczynski SP, Koeffler HP.
    Mod Pathol; 1996 Jan; 9(1):26-31. PubMed ID: 8821952
    [Abstract] [Full Text] [Related]

  • 22. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas.
    Sun Y, Hildesheim A, Lanier AE, Cao Y, Yao KT, Raab-Traub N, Yang CS.
    Oncogene; 1995 Feb 16; 10(4):785-8. PubMed ID: 7862458
    [Abstract] [Full Text] [Related]

  • 23. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.
    Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL.
    Cancer Res; 1994 Oct 01; 54(19):5050-3. PubMed ID: 7923115
    [Abstract] [Full Text] [Related]

  • 24. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK.
    Cancer Res; 1997 Nov 01; 57(21):4868-75. PubMed ID: 9354451
    [Abstract] [Full Text] [Related]

  • 25. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.
    Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJ.
    Cancer Res; 1995 Mar 15; 55(6):1351-4. PubMed ID: 7882335
    [Abstract] [Full Text] [Related]

  • 26. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ, Malandro J, Compitello N, Baylin SB, Graff JR.
    Cell Growth Differ; 1999 Jan 15; 10(1):27-33. PubMed ID: 9950215
    [Abstract] [Full Text] [Related]

  • 27. No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis.
    Ryan A, Al-Jehani RM, Mulligan KT, Jacobs IJ.
    Gynecol Oncol; 1998 Jan 15; 68(1):14-7. PubMed ID: 9454653
    [Abstract] [Full Text] [Related]

  • 28. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
    Biden K, Young J, Buttenshaw R, Searle J, Cooksley G, Xu DB, Leggett B.
    Hepatology; 1997 Mar 15; 25(3):593-7. PubMed ID: 9049204
    [Abstract] [Full Text] [Related]

  • 29. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE, Gorgoulis V, Mariatos G, Zacharatos P, Kotsinas A, Garinis G, Trigidou R, Karameris A, Tsimara-Papastamatiou H, Kouloukousa M, Manolis EN, Kittas C.
    Anticancer Res; 1999 Mar 15; 19(3A):1893-9. PubMed ID: 10470133
    [Abstract] [Full Text] [Related]

  • 30. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.
    Pollock PM, Yu F, Qiu L, Parsons PG, Hayward NK.
    Oncogene; 1995 Aug 17; 11(4):663-8. PubMed ID: 7651729
    [Abstract] [Full Text] [Related]

  • 31. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE, Simpson DJ, Bicknell JE, Talbot AJ, Bates AS, Clayton RN.
    Cancer Res; 1997 Jul 01; 57(13):2703-9. PubMed ID: 9205080
    [Abstract] [Full Text] [Related]

  • 32. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B, Goharderakhshan R, Chang J, Ribeiro-Filho LA, Perinchery G, Franks J, Presti J, Carroll P, Dahiya R.
    J Urol; 2001 Sep 01; 166(3):1088-92. PubMed ID: 11490304
    [Abstract] [Full Text] [Related]

  • 33. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 34. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
    Tanaka T, Iwasa Y, Kondo S, Hiai H, Toyokuni S.
    Oncogene; 1999 Jun 24; 18(25):3793-7. PubMed ID: 10391689
    [Abstract] [Full Text] [Related]

  • 35. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
    Brenner AJ, Paladugu A, Wang H, Olopade OI, Dreyling MH, Aldaz CM.
    Clin Cancer Res; 1996 Dec 24; 2(12):1993-8. PubMed ID: 9816158
    [Abstract] [Full Text] [Related]

  • 36. MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines.
    Liu Q, Yan YX, McClure M, Nakagawa H, Fujimura F, Rustgi AK.
    Oncogene; 1995 Feb 02; 10(3):619-22. PubMed ID: 7845688
    [Abstract] [Full Text] [Related]

  • 37. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
    Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB.
    Cancer Res; 1995 Oct 15; 55(20):4525-30. PubMed ID: 7553621
    [Abstract] [Full Text] [Related]

  • 38. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS, Franklin WA, Drabkin H, Gemmill R, Sidransky D, Anderson MW.
    J Cell Biochem Suppl; 1997 Oct 15; 28-29():64-73. PubMed ID: 9589350
    [Abstract] [Full Text] [Related]

  • 39. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.
    Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE.
    Nat Genet; 1994 Sep 15; 8(1):27-32. PubMed ID: 7726912
    [Abstract] [Full Text] [Related]

  • 40. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
    Merbs SL, Sidransky D.
    Invest Ophthalmol Vis Sci; 1999 Mar 15; 40(3):779-83. PubMed ID: 10067984
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.